Blog: INMED PHARMACEUTICALS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On September 19, 2022, the Company announced that will report financial results
on Friday, September 23, 2022 for the fiscal year ended June 30, 2022.

The information set forth in this Item 7.01, including Exhibits 99.1, is being
furnished and shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section. The information set forth in this
Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference
into any other filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

The following exhibits shall be deemed to be furnished, and not filed:

Exhibit No.   Description
99.1            News release, dated September 19, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document and included as Exhibit 101)


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s